Related references
Note: Only part of the references are listed.Cancer statistics, 2023
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2023)
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11)
Hongsik Kim et al.
CANCER (2022)
Longitudinal patient-reported outcomes and survival among early-stage non-small cell lung cancer patients receiving stereotactic body radiotherapy
Kea Turner et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Circadian rhythms and cancers: the intrinsic links and therapeutic potentials
Li Zhou et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)
The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy
Sarah Badaoui et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2022)
Cancer cells spread aggressively during sleep
Harrison Ball et al.
NATURE (2022)
Blood protein biomarkers in lung cancer
Hong Huang et al.
CANCER LETTERS (2022)
Change in Patients' Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma
Anna Barata et al.
TRANSPLANTATION AND CELLULAR THERAPY (2022)
Sleep Apnea and Insomnia Emerging Evidence for Effective Clinical Management
Jason C. Ong et al.
CHEST (2021)
Redistribution of Monocyte Subsets in Obstructive Sleep Apnea Syndrome Patients Leads to an Imbalanced PD-1/PD-L1 Cross-Talk with CD4/CD8 T Cells
Christina Polasky et al.
JOURNAL OF IMMUNOLOGY (2021)
Patient-Reported Outcomes as Independent Prognostic Factors for Survival in Oncology: Systematic Review and Meta-Analysis
Fabio Efficaee et al.
VALUE IN HEALTH (2021)
Patient-Reported Outcomes From Patients Receiving Immunotherapy or Chemoimmunotherapy for Metastatic Non-Small-Cell Lung Cancer in Clinical Practice
Laurie E. Steffen McLouth et al.
CLINICAL LUNG CANCER (2020)
Differential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation
Carolina Cubillos-Zapata et al.
SLEEP (2020)
Review: The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs)
Wanhai Ke et al.
THORACIC CANCER (2020)
Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
Renee Brady-Nicholls et al.
NATURE COMMUNICATIONS (2020)
CA125 and Ovarian Cancer: A Comprehensive Review
Parsa Charkhchi et al.
CANCERS (2020)
What Do Patients With Non-Small-Cell Lung Cancer Experience? Content Domain for the MD Anderson Symptom Inventory for Lung Cancer
Meagan S. Whisenant et al.
JCO ONCOLOGY PRACTICE (2020)
Prognostic Significance of Patient-Reported Outcomes in Cancer
Kathleen Kerrigan et al.
JCO ONCOLOGY PRACTICE (2020)
Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer
Fabrice Denis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Obstructive sleep apnea basics
Jessica Vensel Rundo
CLEVELAND CLINIC JOURNAL OF MEDICINE (2019)
Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment
Afshin Moradi et al.
CANCER AND METASTASIS REVIEWS (2019)
Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea
Carolina Cubillos-Zapata et al.
RESPIROLOGY (2019)
Prognostic value of patient-reported outcomes from international randomised clinical trials on cancer: a systematic review
Justyna Mierzynska et al.
LANCET ONCOLOGY (2019)
Truthfulness in patient-reported outcomes: factors affecting patients' responses and impact on data quality
Eric M. Chang et al.
PATIENT-RELATED OUTCOME MEASURES (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC)
Julie R. Brahmer et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Application and Benefits of Web-Mediated Symptom Reporting for Patients Undergoing Immunotherapy: A Clinical Example
Fabrice Denis et al.
CASE REPORTS IN ONCOLOGY (2018)
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour et al.
LANCET ONCOLOGY (2017)
Monitoring of KRAS-mutated ctDNA to discriminate pseudo-progression from true progression during anti-PD-1 treatment of lung adenocarcinoma
Nicolas Guibert et al.
ONCOTARGET (2017)
Evaluation of the Feasibility of Screening Patients for Early Signs of Lung Carcinoma inWeb Search Logs
Ryen W. White et al.
JAMA ONCOLOGY (2017)
Screening for Pancreatic Adenocarcinoma Using Signals From Web Search Logs: Feasibility Study and Results
John Paparrizos et al.
JOURNAL OF ONCOLOGY PRACTICE (2016)
The use of tumour volumetrics to assess response to therapy in anticancer clinical trials
Gregory V. Goldmacher et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Comorbidity between sleep apnea and insomnia
Antonio Beneto et al.
SLEEP MEDICINE REVIEWS (2009)
Sleep disturbances and quality of life in lung cancer patients undergoing chemotherapy
Mei-Ling Chen et al.
LUNG CANCER (2008)
Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance
HEALTH AND QUALITY OF LIFE OUTCOMES (2006)
The role of actigraphy in sleep medicine
A Sadeh et al.
SLEEP MEDICINE REVIEWS (2002)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Symptoms in adults with lung cancer: A systematic research review
ME Cooley
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2000)
Share Paper
